Company Overview
- Website
- jupiterorphan.com
- Employees
- 8
- Industry
- Materials/Manufacturing
- SIC Code
-
2834 - Pharmaceutical Preparations
Financials & Stats
Revenue
$10B
Recent News & Media
Why Jupiter Neurosciences, Inc.’s (JUNS) Stock Is Down 20.93%
- Jan 16, 2025
- aaii.com
Current Drug Repurposing Strategies for Rare Neurodegenerative Disorders
- Oct 17, 2024
- pmc.ncbi.nlm.nih.gov
Frataxin Mitochondrial (Friedreich Ataxia Protein or FXN or EC 1.16.3.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
- Jul 27, 2022
- globaldata.com
Jupiter Medical Center Receives $4 Million to Enhance Emergency Services
- Sep 15, 2021
- southfloridahospitalnews.com
Jupiter Orphan Therapeutics, Inc. Announces New Corporate Name, Jupiter Neurosciences, Inc.
- Sep 14, 2021
- biospace.com
Benefits of a novel highly bioavailable resveratrol formulation, JOTROL, for Alzheimer’s disease
- Dec 7, 2020
- alz-journals.onlinelibrary.wiley.com
Company Leadership
Jupiter Orphan Therapeutics Industry Tags
Companies Similar to Jupiter Orphan Therapeutics
Analyze industry trends and opportunities by examining competitors and companies comparable to Jupiter Orphan Therapeutics, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 10M | 16 | Bethlehem, PA | 2005 | |
| 10M | 28 | New York, NY | 2013 | |
| 10M | Pittsburgh, PA | |||
| 10M | 8 | Houston, TX | 2011 | |
| 10M | 3 | Cary, NC | 2009 |